Stock listing
MNPR Stock Price, News, Filings & Events — Monopar Therapeutics Inc.
Selected listing: MNPR · NASDAQ · USD · US
This page tracks Monopar Therapeutics Inc.'s MNPR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MNPR:NASDAQ. MNPR:NASDAQ is the stock-level entry point for investors researching Monopar Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Monopar Therapeutics Inc. is a public company traded under the ticker MNPR in the American market. The company has a market capitalization of approximately $736 million. Monopar focuses on developing innovative therapies for cancer treatment.
- Ticker
- MNPR:NASDAQ
- Asset type
- Stock
- Market cap
- $740.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Monopar Therapeutics Inc. MNPR:NASDAQ stock context
This page tracks Monopar Therapeutics Inc.'s MNPR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MNPR:NASDAQ. MNPR:NASDAQ is the stock-level entry point for investors researching Monopar Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Monopar Therapeutics Inc. is a public company traded under the ticker MNPR in the American market. The company has a market capitalization of approximately $736 million. Monopar focuses on developing innovative therapies for cancer treatment.
Latest news from Monopar Therapeutics Inc.
Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AAS...
August 19, 2026
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 13, 2026
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 12, 2026
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
July 22, 2026
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Comm...
July 20, 2026
Research Monopar Therapeutics Inc.
Monopar Therapeutics Inc. investor report
Review AI stock analysis and investor report context for MNPR:NASDAQ.
Monopar Therapeutics Inc. company profile
View the public company page for Monopar Therapeutics Inc. on 6ix.
Monopar Therapeutics Inc. news
Read company news and market updates connected to Monopar Therapeutics Inc..
Monopar Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Monopar Therapeutics Inc..
Alternate listings
1IY0:TRADEGATE
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
A40JML:LSX
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
1IY0:GETTEX
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
A40JML:LS
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
MNPR:BOATS
US · USD
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
1IY0:FWB
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
1IY0:MUN
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.
1IY0:SWB
DE · EUR
Alternate listing for Monopar Therapeutics Inc.; the primary context on this page is MNPR:NASDAQ.